All Pharma News
US FDA grants Orphan Drug Designation for iOnctura`s autotaxin cancer therapy

US FDA grants Orphan Drug Designation for iOnctura`s autotaxin cancer therapy
PR NEWSWIRE
07 Mar 2024
Share Share
Updated clinical safety and efficacy data for iOnctura`s roginolisib presented

Updated clinical safety and efficacy data for iOnctura`s roginolisib presented
PR NEWSWIRE
08 Dec 2023
Share Share
iOnctura to present research on roginolisib and IOA-359 at ASH

iOnctura to present research on roginolisib and IOA-359 at ASH
PR NEWSWIRE
03 Nov 2023
Share Share
iOnctura announces FDA clearance of IND application for roginolisib

iOnctura announces FDA clearance of IND application for roginolisib
PR NEWSWIRE
31 Oct 2023
Share Share
New research highlights potential of iOnctura strategy combining autotaxin

New research highlights potential of iOnctura strategy combining autotaxin
PR NEWSWIRE
19 Oct 2023
Share Share
iOnctura to present research at leading scientific conferences in June 2023

iOnctura to present research at leading scientific conferences in June 2023
PR NEWSWIRE
01 Jun 2023
Share Share
iOnctura exp&s pipeline & receives development grant from Health Holl& & KWF

iOnctura exp&s pipeline & receives development grant from Health Holl& & KWF
BUSINESSWIRE
03 May 2023
Share Share
iOnctura and Clavius exercise option for TGF-? pathway inhibitor

iOnctura and Clavius exercise option for TGF-? pathway inhibitor
PHARMACEUTICAL TECHNOLOGY
03 May 2023
Share Share
iOnctura awarded UK`s MHRA Innovation Passport for entry into ILAP

iOnctura awarded UK`s MHRA Innovation Passport for entry into ILAP
PR NEWSWIRE
28 Mar 2023
Share Share
iOnctura reveals roginolisib research results

iOnctura reveals roginolisib research results
PHARMATIMES
17 Mar 2023
Share Share